Pasar al contenido principal

Stem Cells and Cancer 2007

1 Oct 07

BARCELONA, Spain.  1 - 3 OCTOBER, 2007

An IRB Barcelona and BBVA Foundation conference that will provide an interdisciplinary forum for researchers interested in the connections between stem cell biology and cancer to meet and discuss the latest advances in this field.



Stem cells play a crucial role in all aspects of biology from embryo development to the maintenance of adult tissues. Adult stem cells are unique among somatic cells in that they can undergo asymmetric cell divisions and are responsible for the self-renewal and repair of tissues throughout the lifespan. Recently, a population of cells exhibiting stem cell properties has been isolated from a number of solid and liquid tumours. These cancer stem cells are believed to be responsible for tumour relapse as they can efficiently initiate and regenerate a new tumour similar to the tumour of origin. In this meeting we will explore the latest developments in the genetic and biochemical mechanisms that regulate stem cell specification and self-renewal in normal and tumour tissues. Specific topics to be discussed include the characterisation of stem cell niches, the role of stem cells in tumor initiation and the parallelisms between normal and cancer stem cells and their significance for tumour prognosis and therapy.

The conference will provide an interdisciplinary forum for researchers interested in the connections between stem cell biology and cancer to meet and discuss the latest advances in this field.

Organised by IRB Barcelona with the collaboration of the Banco Bilbao Vizcaya Argentaria Foundation (fBBVA).

Hosted by the Institut d'Estudis Catalans (IEC).

For more information, please contact the Barcelona BioMed Conference Secretariat at

Registration deadline: July 31, 2007

There is no registration fee for this conference, but the number of participants is limited to 120.

Participants are invited to submit abstracts, 10 of which will be selected for short talk presentations. If the meeting is oversubscribed, priority will be given to people submitting abstracts. Abstracts should include a title, authors, affiliations, summary (max 250 words) and references.


Download the Stem Cells and Cancer stemcellsprogramme.pdf.


The BARCELONA BIOMED CONFERENCE on STEM CELLS AND CANCER will be hosted by the Institut d'Estudis Catalans (IEC) in the heart of downtown Barcelona. Talks will take place in the Sala Prat de Riba.

Institut d'Estudis Catalans
C. del Carme, 47
08001 Barcelona

Tel +34 932 701 620
Fax +34 932 701 180


How to reach the IEC by public transport:

  • metro Metro
    Plaça Catalunya (lines 1 and 3)
    Liceu (line 3)
  • ffcc FGC
    Plaça Catalunya (train from Sarrià)
  • renfe Renfe
    Plaça Catalunya
  • bus Buses
    41, 55, 141 (Plaça Catalunya stop)
    14, 18, 59, 91 (Rambla stop)

Speakers will be lodged at the Hotel Catalonia Ramblas
c/ Pelayo, 28
08001 Barcelona
Tel. +34 93.316.84.00
Fax. +34 93.316.84.01

Help in finding accommodation in Barcelona can be obtained through the following websites:

For more information about Barcelona, you can also consult the IRB Barcelona web section "Living in Barcelona".

fbbva iec



  • Eduard Batlle, IRB Barcelona (Barcelona, Spain)
  • Hans Clevers, Hubrecht Laboratory (Utrecht, Netherlands)

Invited Speakers:

  • Maria Blasco, Spanish National Cancer Centre, CNIO (Madrid, Spain)
  • Michael F. Clarke, Stanford Comprehensive Cancer Center (Stanford, USA)
  • John E. Dick, Toronto General Research Institute (Toronto, Canada)
  • Peter B. Dirks, Hospital for Sick Children (Toronto, Canada)
  • Elaine Fuchs, The Rockefeller University (New York, USA)
  • Cayetano González , IRB Barcelona (Barcelona, Spain)
  • Jürgen Knoblich, Institute of Molecular Biotechnology of the Austrian Academy of Sciences (Vienna, Austria)
  • Daniel Louvard, Institut Curie (Paris, France)
  • Joan Massagué, Memorial Sloan-Kettering Cancer Center (New York, USA)
  • Bruce A. Morgan, Harvard Medical School (Cambridge, USA)
  • Sean J. Morrison, University of Michigan (Ann Arbor, USA)
  • Claus Nerlov, EMBL-Monterotondo (Monterotondo, Italy)
  • Freddy Radtke, Swiss Institute for Experimental Cancer Research (Epalinges, Switzerland)
  • Shahin Rafii, Cornell University Medical College (New York, USA)
  • Austin Smith, Wellcome Trust Centre for Stem Cell Research (Cambridge, UK)
  • Andreas Trumpp, Swiss Institute for Experimental Cancer Research (Epalinges, Switzerland)
  • Maarten van Lohuizen, The Netherlands Cancer Institute (Amsterdam, Netherlands)
  • Jane Visvader, The Walter and Eliza Hall Institute of Medical Research (Victoria, Australia)